What is Histopath?
Histopath is a distinguished provider of anatomic pathology services, operating primarily in Southeast Texas. Renowned for its commitment to delivering accurate, timely, and dependable laboratory results, the company leverages a dedicated team of board-certified Pathology Assistants and Histology Technicians. Histopath serves a diverse range of hospitals within the region, offering comprehensive services that include pathology, histology, immunohistochemistry, and specialized diagnostic capabilities, particularly in breast pathology and gastrointestinal pathology. Since its inception in 1983, Histopath has consistently upheld a high benchmark of excellence in anatomical pathology.
How much funding has Histopath raised?
Histopath has raised a total of $350K across 1 funding round:
Debt
$350K
Debt (2020): $350K with participation from PPP
Key Investors in Histopath
PPP
Public-Private Partnership
What's next for Histopath?
With the recent influx of capital, Histopath is strategically positioned to enhance its service offerings and potentially expand its geographic reach. The large-scale late-stage funding indicates a focus on scaling operations, investing in advanced diagnostic technologies, and strengthening its market leadership. Future developments may include further integration of AI-driven diagnostic tools, expanding its team of specialists, and forging new partnerships to broaden its client base. This strategic investment is expected to fuel innovation and reinforce Histopath's reputation as a premier provider of pathology services.
See full Histopath company page
